期刊文献+

乳腺癌MRMT-1细胞局部骨转移大鼠模型的研究 被引量:2

Research of rat model of bone metastasis from rat mammary tumor MRMT-1 cells
原文传递
导出
摘要 目的 研究乳腺癌MRMT-1细胞局部骨转移大鼠模型在痛觉反应、影像学、病理学和分子生物学等方面的表现,为进一步的发病机制和药理学研究提供资料.方法 将32只雌性SD大鼠用随机数字表法分为假手术组和模型组各16只,在模型组大鼠胫骨内注射乳腺癌MRMT-1细胞,引起局部骨转移.造模后19d测定痛觉反应,21d处死大鼠取材,测定肿瘤体积,用X线对骨质损伤进行评分并测定骨密度(BMD),HE染色观察病理形态改变,抗酒石酸酸性磷酸酶(TRAP)法染色观察破骨细胞,免疫组织化学法检测核因子κB受体活化因子配体(RANKL)和骨保护素(OPG)水平,并计算比值;实时荧光定量反转录聚合酶链反应(RT-PCR)法检测甲状旁腺激素相关蛋白(PTHrP)水平.结果 与假手术组比较,模型组存在痛觉异常状态(P<0.01);胫骨在X线下损伤评分较高(P<0.01).模型组和假手术组大鼠左侧胫骨的BMD分别为(0.11 ±0.01)g/cm2和(0.13±0.02)g/cm2(P< 0.05).模型组胫骨标本上肿瘤生长明显,体积为(1082.73±679.44)mm3,而假手术组无肿瘤生长(P<0.01),病理可见混合性骨转移,但以溶骨性病变为主;伴有破骨细胞数量明显增多,达到(40.84±25.59)个/高倍视野,而假手术组仅为(1.88±2.92)个/高倍视野(P<0.01).转移灶局部RANKL水平无明显变化,OPG水平下降(P<0.05),OPG/RANKL比值和PTHrP下降(P<0.05).结论 乳腺癌MRMT-1细胞局部骨转移大鼠模型存在癌痛、骨质破坏,甚至病理性骨折等表现.其发病机制可能是MRMT-1细胞在浸润生长过程中打破了OPG-RANKL-RANK系统的平衡,从而激活破骨细胞,引起骨吸收作用亢进,引起各种表现. Objective To study the characteristics of rat model of bone metastasis from breast cancer,which receiving intra-tibial injection of MRMT-1 rat breast cancer cells.Methods Female SD rats were divided randomly into sham operation group and model group.Sham operation group were intra-tibial injected normal saline,while model group were injected the MRMT-1 cells to develop model.On day 19 after operation,allodynia and hyperalgesia were tested.All rats were killed on day 21,tibias were collected to measure the volume of tumors,determinate bone mineral density (BMD) and bone mineral capacity (BMC).Through HE staining,tartrate-resistant acid phosphatase (TRAP) staining and immunohistochemistry staining to observe the bone pathological changes,count osteoclasts and semi-quantitatively measure expressions of proliferating cell nuclear antigen (PCNA),osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL).By real-time quantitative RT-PCR,expression of parathyroid hormone related protein (PTHrP) was determinated.Results Model group displayed mechanical allodynia and hyperalgesia (P 〈 0.01),bone destruction was found by image examination (P 〈 0.01).BMD of left tibia decreased to (0.11±0.01) g/cm2 from (0.13±0.02) g/cm2.In the model tibia,visible tumor growth could be seen,and mixed bone lesion was seen through HE staining sections.Osteoclast enhanced from (1.88±2.92)/HP to (40.84±25.59)/HP (P 〈 0.01),PTHrP and OPG reduced (P 〈 0.05),but RANKL did not change.Conclusion The model of bone metastasis from breast cancer show characteristics of cancer pain and bone lesion.The injury mechanism is to break balance of OPG-RANKL-RANK system by inhibiting OPG,these changes would cause excessive activation of osteoclasts,which induced hyperfunction of bone resorption.
出处 《肿瘤研究与临床》 CAS 2013年第5期289-292,共4页 Cancer Research and Clinic
基金 国家自然科学基金面上项目
关键词 乳腺肿瘤 大鼠 模型 动物 骨转移 癌痛 Breast neoplasms Rat Models, animal Bone metastasis Cancer pain
  • 相关文献

参考文献12

  • 1赵佳,王水.乳腺癌骨转移动物模型的研究进展[J].国际外科学杂志,2006,33(2):142-145. 被引量:5
  • 2Medhurst SJ, Walker K, Bowes M, et al. A rat model of hone cancerpain. Pain, 2002,96: 129-140.
  • 3谭煌英,于莉莉,高福云,崔建,潘琳,田鑫,程志强,贾立群,李佩文.大鼠骨癌痛模型的建立及组织学研究[J].癌症进展,2005,3(1):75-79. 被引量:17
  • 4谭煌英,高福云,崔建,武晓勤,刘国玲,李圆,李佩文.康莱特注射液对癌症痛大鼠痛行为和肿瘤生长的影响[J].中国中医药信息杂志,2006,13(1):39-42. 被引量:11
  • 5Roudier MP, Bain SD, Dougall WC. Effects of the RANKL inhibitor,osteoprotegerin,on the pain and histopathology of hone cancer in rats.Clin Exp Metastasis, 2006,23: 167-175.
  • 6Ogawa K, Mukai T, Asano D, et al. Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastaticbone pain in an animal model. J Nucl Med, 2007, 48: 122-127.
  • 7Yao S, Pan F, Wise GE. Chronological gene expression of parathyroidhormone-related protein (PTHrP) in the stellate reticulum of (he rat-implications for tooth eruption. Arch Oral Biol,2007, 52: 228-232.
  • 8Deschner J, Wypasek E, Ferretti M, et al. Regulation of RANKL bybiomechanical loading in fibrochondrocytes of meniscus. J Biomech,2006, 39:1796-1803.
  • 9Livak KJ, Schmittgen TD. Analysis of relative gene expression datausing real-time quantitative PCR and the 2-iiAa method. Methods,2001,25:402-408.
  • 10Rosen LS, Gordon DH, Dugan W Jr, et al. Zoledronic acid is superiorto pamidronate for the treatment of hone metastases in breastcarcinoma patients with at least one osteolytic lesion. Cancer, 2004,100: 36-43.

二级参考文献29

  • 1谭煌英,于莉莉,高福云,崔建,潘琳,田鑫,程志强,贾立群,李佩文.大鼠骨癌痛模型的建立及组织学研究[J].癌症进展,2005,3(1):75-79. 被引量:17
  • 2[2]Medhurst SJ,Walker K,Bowes M,et al.A rat model of bone cancer pain[J].Pain,2002,96(1-2):129-140.
  • 3[4]Walker K,Medhurst SJ,Kidd BL,et al.Disease modifying and anti-nociceptive effects of the bisphosphonate,zoledronic acid in a model of bone cancer pain[J].Pain,2002,100(3):219-229.
  • 4[5]Fox A,Medhurst S,Courade JP,et al.Anti-hyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat[J].Pain,2004,107(1-2):33-40.
  • 5[6]Donovan-Rodriguez T,Dickenson AH,Urch CE.Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain[J].Anesthesiology,2005,102(1):132-140.
  • 6[1]Schwei MJ, Honore P, Rogers SD, et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci, 1999, 19 (24) : 10886
  • 7[2]Medhurst SJ, Walker K, Bowes M, et al. A rat model of bone cancer pain. Pain, 2002, 96 ( 1 - 2) : 129
  • 8[3]Walker K, Medhurst SJ, Kidd BL, et al. Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain. Pain, 2002, 100 (3) :219
  • 9[4]Fox A, Medhurst S, Courade JP, et al. Anti-hyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat. Pain, 2004, 107 (1-2) :33
  • 10[5]Kim SH, Chang JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat.Pain, 1992, 50 (3) :355

共引文献28

同被引文献21

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部